Guidelines for the treatment of Crohn's disease in children.
This paper shows guidelines for the treatment of Crohn's disease in children by the Working Group of the Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition (Chair: Yuichiro Yamashiro) and the Japanese Society for Pediatric Inflammatory Bowel Disease (Chair: Akio Kobayashi). The points in which these guidelines differ from those for adult patients are as follows. (i) Total enteral nutrition in the form of an elemental formula is indicated as primary therapy for children with Crohn's disease at onset as well as the active stage. Oral mesalazine is used together. (ii) Total parenteral nutrition (TPN) with oral mesalazine is required for children with serious illness. The use of a corticosteroid should be withheld for at least 1 week after TPN has been started. (iii) When TPN is not considered to be effective, additional corticosteroid is used. Full doses of corticosteroid should be used for at least 2 weeks after clinical improvement has been achieved, and then the dose of the corticosteroid should be tapered carefully. (iv) When surgery is indicated in pediatric patients with stricture or fistula formation and complicated by persistent growth failure despite medical therapy, the optimum time for surgery is thought to be before epiphyseal plates have been closed.
Department of Pediatrics, Sapporo Kosei General Hospital, Sapporo, Japan. mutsukon@jahokkaidoukouseiren.or.jp
Konno
Mutsuko
M
Kobayashi
Akio
A
Tomomasa
Takeshi
T
Kaneko
Hiroaki
H
Toyoda
Shigeru
S
Nakazato
Yutaka
Y
Nezu
Riichiro
R
Maisawa
Shun-Ichi
S
Miki
Kazunori
K
D002648:Child; D003424:Crohn Disease / Q000628:therapy*; D006801:Humans; D007564:Japan